亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

安徽立創生物科技有限公司  

生物醫藥研發、生產、銷售,醫藥中間體的技術開發,技術轉讓,技術咨詢,化工原料及產品(除危險品和易制毒化學品)銷售,自營和代理各類商品及技術的進出口業務,(國家限定企業經營或禁止出口的商品除外)。(依法須經批準的項目,經相關部門批準后方可開展經營活動)

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:武冬杰
  • 電話:1332-9263899
  • 郵件:2012168181@qq.com
  • 傳真:0562-5822555
  • QQ:2012168181
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > S-4-氯-3-羥基***
S-4-氯-3-羥基***
單價 1.00 / kg對比
銷量 暫無
發貨 安徽銅陵市付款后3天內
庫存 20000kg起訂1kg
品牌 安徽立創
含量 99
過期 長期有效
更新 2020-03-13 14:36
 
詳細信息
(S)-4-氯-3-羥基*** [1]  ,外觀無色至淡黃色液體為阿托伐他汀中間體
CAS: 127913-44-4 [1] 
中文名稱: (S)-4-氯-3-羥基***
中文別名 :S(-)-4-氯-3-羥基***;S-4-氯-3-羥基***
英文名稱 :(S)-(-)-4-chloro 3-hydroxybutyronitrile
英文別名 :(3R)-4-chloro-3-hydroxybutanenitrile;
(3S)-4-chloro-3-hydorxybutyronitrile;
(3S)-4-chloro-3-hydroxybutanenitrile;
(S)-4-Chloro-3-hydroxybutyronitrile;
S-(-)-4-Chloro-3-hydroxybutyronitrile;
S-(-)-4-chloro-3-hydorxy butyronitrile;
(S)-(-)-4-Chloro-3-hydroxybutyronitrile;
分子式: C4H6ClNO
分子量 :119.5495
InChI :InChI=1/C4H6ClNO/c5-3-4(7)1-2-6/h4,7H,1,3H2/t4-/m0/s1
©2025 安徽立創生物科技有限公司 版權所有   技術支持:化工網   訪問量:8175  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |